A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)Jingwei Yu, Huilai Zhang, Lanfang Li et al.|Blood|2025Cited by 0